跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11 条关于
“Sermonix”
全部
11
临床试验
0
药物
0
机构
1
资讯
10
去年
Lasofoxifene Shows Promise in Neoadjuvant Breast Cancer Treatment: I-SPY 2 Trial
去年
Lasofoxifene Enhances Immunotherapy Efficacy by Promoting Antitumor Activity
去年
Lasofoxifene Shows Promise in Neoadjuvant Breast Cancer Treatment: I-SPY 2 Trial
去年
Lasofoxifene Shows Promise in Early Breast Cancer Treatment, I-SPY 2 Trial Data Reveal
去年
Sermonix and Henlius Initiate Phase 3 ELAINE-3 Trial in China for Lasofoxifene Plus Abemaciclib in Advanced Breast Cancer
去年
Lasofoxifene Shows Promise in Improving Urogenital Symptoms for ESR1-Mutated Breast Cancer Patients
9个月前
Athira Pharma Acquires Late-Stage Breast Cancer Drug Lasofoxifene in $90 Million Deal
9个月前
Athira Pharma Secures $236 Million Financing and Exclusive Rights to Lasofoxifene for ESR1-Mutant Metastatic Breast Cancer
去年
Lasofoxifene Shows Early Activity in HR+/HER2- Breast Cancer via Ki-67 Suppression
上个月
LeonaBio On Track to Complete Phase 3 ELAINE-3 Enrollment for Lasofoxifene in ESR1-Mutated Metastatic Breast Cancer in 4Q 2026